Login to Your Account



House bill would boost intercenter collaboration, streamline FDA reviews

By Liz Hollis
Staff Writer

Saturday, June 11, 2016

With an eye toward streamlining reviews of increasingly complex medical products and enhancing collaboration between the FDA centers, two leading lawmakers have offered a bill that proposes the establishment of "intercenter institutes" within the agency for major disease areas.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription